Genmab | GEN - Capital Y Las Reservas





Capital Y Las Reservas Cambio Fecha
Agios Pharmaceuticals USD 1.11B 84M 2026-03
Almirall EUR 1.49B 24.03M 2025-12
Amarin USD 449.41M 9.87M 2026-03
Amgen USD 9.19B 532M 2026-03
argenx SE USD 7.32B 1.23B 2025-12
AstraZeneca USD 47.33B 1.33B 2026-03
Bayer EUR 28.85B 2.9B 2026-03
BioMarin Pharmaceutical USD 6.21B 125.11M 2026-03
Demant DKK 9.84B 446M 2025-12
Exelixis USD 1.94B 225.57M 2026-03
Fresenius Medical Care EUR 14.2B 13.95B 2026-03
Genmab DKK 5.85B 96M 2025-12
GlaxoSmithKline GBP 17.42B 1.05B 2026-03
GN Store Nord DKK 10.12B 4.76B 2026-03
GRIFOLS EUR 5.46B 171M 2026-03
Hikma Pharmaceutical USD 2.59B 42M 2025-12
Insmed USD 704.85M 34.12M 2026-03
Lakefront Biotherapeutics EUR 3.25B 17.5M 2026-03
Lonza CHF 9.13B 513M 2025-12
Merck EUR 29.74B 1.15B 2026-03
Novartis USD 38.93B 7.2B 2026-03
Regeneron Pharmaceuticals USD 31.42B 166.7M 2026-03
Roche Holding CHF 33.8B 758M 2025-12
Sanofi EUR 72.81B 1.1B 2026-03
UCB EUR 10.87B 1.18B 2025-12